Letter to the Editor: Further consideration of combining clinical trials of er-xian decoction for menopausal symptoms

American Journal of Chinese Medicine

Volumn 36, Issue 5, 2008, Pages 1017-1018

  Lee, Myeong Soo ^a,b   Shin, Byung Cheul ^c  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; ER XIAN; UNCLASSIFIED DRUG; ER XIAN DECOCTION; ER-XIAN DECOCTION; HERBACEOUS AGENT;

CHINA; CLINICAL TRIAL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MENOPAUSAL SYNDROME; METHODOLOGY; SYSTEMATIC ERROR; UNITED KINGDOM; DRUG EFFECT; FEMALE; MENOPAUSE; NOTE;

CLINICAL TRIALS AS TOPIC; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MENOPAUSE;

EID: 57349112869     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X08006429     Document Type: Letter

References (6)

1. Chen, X.Y., W.C.S. Cho, S.C.W. Sze and Y. Tong. Treatment of menopausal symptoms with Er-xian decoction: A systematic review. Am. J. Chin. Med. 36: 233-244, 2008.
2. Ernst, E. and M.H. Pittler. Alternative therapy bias. Nature 385: 480, 1997.
3. Higgins, J.P.T., S. Greens and editors. Cochrane handbook for systematic reviews of interventions 4.2.6 [updated September 2006]. In: Cochrane Library. Issue 4. JohnWiley & Sons, Ltd., Chichester, UK, 2006.
4. Shang, A., K. Huwiler, L. Nartey, P. Juni and M. Egger. Placebo-controlled trials of Chinese herbal medicine and conventional medicine comparative study. Int. J. Epidemiol. 36: 1086-1092, 2007.
5. Slavin, R.E. Best evidence synthesis: An intelligent alternative to meta-analysis. J. Clin. Epidemiol. 48: 9-18, 1995.
6. Thompson, S.G. Why and how sources of heterogeneuty should be investigated. In: Egger, M., G.D. Smith and D.G. Altman (eds.) Systematic Reviews in Health Care. BMJ Publishing, London, 2001, pp. 157-175.